Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 219

1.

Harnessing the Power of Community-Based Participatory Research: Examining Knowledge, Action, and Consciousness in the PROUD Study.

Stanley D, Marshall Z, Lazarus L, LeBlanc S, Heighton T, Preater B, Tyndall M.

Soc Work Public Health. 2015 May-Jun;30(3):312-23. doi: 10.1080/19371918.2014.1001935. Epub 2015 Mar 16.

PMID:
25774651
2.

Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: A comprehensive narrative overview of English-language studies.

Fischer B, Blanken P, Da Silveira D, Gallassi A, Goldner EM, Rehm J, Tyndall M, Wood E.

Int J Drug Policy. 2015 Apr;26(4):352-63. doi: 10.1016/j.drugpo.2015.01.002. Epub 2015 Jan 14.

PMID:
25662894
3.

Effect of rapid HIV testing on HIV incidence and services in populations at high risk for HIV exposure: an equity-focused systematic review.

Pottie K, Medu O, Welch V, Dahal GP, Tyndall M, Rader T, Wells G.

BMJ Open. 2014 Dec 15;4(12):e006859. doi: 10.1136/bmjopen-2014-006859.

4.

Establishing a community-based participatory research partnership among people who use drugs in Ottawa: the PROUD cohort study.

Lazarus L, Shaw A, LeBlanc S, Martin A, Marshall Z, Weersink K, Lin D, Mandryk K, Tyndall MW; PROUD Community Advisory Committee.

Harm Reduct J. 2014 Oct 13;11(1):26. doi: 10.1186/1477-7517-11-26.

5.

Canadian consensus statement on HIV and its transmission in the context of criminal law.

Loutfy M, Tyndall M, Baril JG, Montaner JS, Kaul R, Hankins C.

Can J Infect Dis Med Microbiol. 2014 May;25(3):135-40.

6.

Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013).

Klein MB, Rollet-Kurhajec KC, Moodie EE, Yaphe S, Tyndall M, Walmsley S, Gill J, Martel-Laferriere V, Cooper C; Canadian Co-infection Cohort Investigators.

AIDS. 2014 Aug 24;28(13):1957-65. doi: 10.1097/QAD.0000000000000377.

PMID:
25259703
7.

Charitable giving for HIV and AIDS: results from a Canadian national survey.

Allman D, Calzavara L, Worthington C, Tyndall M, Adrien A, Walters M, White S, Jones MK.

PLoS One. 2014 Aug 25;9(8):e103184. doi: 10.1371/journal.pone.0103184. eCollection 2014.

8.

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.

Cooper C, Rollet-Kurhajec KC, Young J, Vasquez C, Tyndall M, Gill J, Pick N, Walmsley S, Klein MB; Canadian Co-infection Cohort Study Investigators.

HIV Med. 2015 Jan;16(1):24-31. doi: 10.1111/hiv.12168. Epub 2014 May 18.

9.

Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.

Cox J, Maurais E, Hu L, Moodie EE, Law S, Bozinoff N, Potter M, Rollet K, Hull M, Tyndall M, Cooper C, Gill J, Saeed S, Klein MB; Canadian Co-infection Cohort (CTN 222).

Drug Alcohol Depend. 2014 Apr 1;137:121-8. doi: 10.1016/j.drugalcdep.2014.01.014. Epub 2014 Jan 30.

PMID:
24559606
10.

Sex-for-Crack exchanges: associations with risky sexual and drug use niches in an urban Canadian city.

Duff P, Tyndall M, Buxton J, Zhang R, Kerr T, Shannon K.

Harm Reduct J. 2013 Nov 15;10:29. doi: 10.1186/1477-7517-10-29.

11.

The Second Canadian Symposium on hepatitis C virus: a call to action.

Grebely J, Bilodeau M, Feld JJ, Bruneau J, Fischer B, Raven JF, Roberts E, Choucha N, Myers RP, Sagan SM, Wilson JA, Bialystok F, Tyrrell DL, Houghton M, Krajden M; National CIHR Research Training Program in Hepatitis C.

Can J Gastroenterol. 2013 Nov;27(11):627-32.

12.

Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents.

Alavi M, Raffa JD, Deans GD, Lai C, Krajden M, Dore GJ, Tyndall MW, Grebely J.

Liver Int. 2014 Sep;34(8):1198-206. doi: 10.1111/liv.12370. Epub 2013 Nov 20.

PMID:
24164865
13.

Crack across the Americas - a massive problem in continued search of viable answers: exemplary views from the North (Canada) and the South (Brazil).

Fischer B, Cruz MS, Bastos FI, Tyndall M.

Int J Drug Policy. 2013 Nov;24(6):631-3. doi: 10.1016/j.drugpo.2013.09.003. Epub 2013 Sep 18. No abstract available.

PMID:
24120442
14.

Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis.

Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, Klein MB; Canadian Co-infection Cohort Investigators.

Clin Infect Dis. 2013 Sep;57(5):663-70. doi: 10.1093/cid/cit378. Epub 2013 Jun 28.

15.

Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.

Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa JP, Abdul-Jauwad H, Joseph P, Koenig E, Metzger D, Sobieszycz M, Tyndall M, Zorilla C.

AIDS. 2013 Jul 17;27(11):1763-70. doi: 10.1097/QAD.0b013e328360c83e. Erratum in: AIDS. 2013 Sep 10;27(14):2321. Adbul-Jauwad, Hend [corrected to Abdul-Jauwad, Hend].

16.

Adoption of the chronic care model to improve HIV care: in a marginalized, largely aboriginal population.

Tu D, Belda P, Littlejohn D, Pedersen JS, Valle-Rivera J, Tyndall M.

Can Fam Physician. 2013 Jun;59(6):650-7.

17.

Agnosia for accents in primary progressive aphasia.

Fletcher PD, Downey LE, Agustus JL, Hailstone JC, Tyndall MH, Cifelli A, Schott JM, Warrington EK, Warren JD.

Neuropsychologia. 2013 Aug;51(9):1709-15. doi: 10.1016/j.neuropsychologia.2013.05.013. Epub 2013 May 27.

18.

A brief tool to assess capacity to consent for medical care among homeless individuals with problematic substance use: study protocol.

Taylor D, Masse L, Ho A, Rekart ML, Tyndall M, Henry B, Clifton J, Peters L, Ogilvie G, Buxton J.

Arch Public Health. 2013 May 8;71(1):11. doi: 10.1186/0778-7367-71-11.

19.

Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada.

Deans GD, Raffa JD, Lai C, Fischer B, Krajden M, Amin J, Walter SR, Dore GJ, Grebely J, Tyndall MW.

CMAJ Open. 2013 May 23;1(2):E68-76. doi: 10.9778/cmajo.20130002. eCollection 2013 May.

20.

Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes.

Frankwich K, Tibble C, Torres-Gonzalez M, Bonner M, Lefkowitz R, Tyndall M, Schmid-Schönbein GW, Villarreal F, Heller M, Herbst K.

J Inflamm (Lond). 2012 Oct 1;9(1):35. doi: 10.1186/1476-9255-9-35.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk